Efficacy of the National Thalassaemia and Sickle Cell Disease Prevention Programme in Northern Greece: 15-Year Experience, Practice and Policy Gaps for Natives and Migrants

References

• Weatheral DJ, Clegg JB. The Thalassaemia Syndromes, 4th ed. Oxford (Oxfordshire, UK): Blackwell Scientific, 2001.
   Google Scholar
• Williams T, Weatherall DJ. World distribution, population genetics and health burden of the hemoglobinopathies. Cold Spring Harbor Perspect Med 2012;2:1–14.
   Web of Science ®Google Scholar
• Loutradi-Anagnostou A. Prevention of thalassaemia in Greece: 25 year experience. The 8th International Conference on Thalassaemia and Haemoglobinopathies, held in Athens, Greece, October 18-21, 2001. Abstract Book: 16–18.
   Google Scholar
• Samara M, Chiotoglou I, Kalamaras A, et al. Large-scale population genetic analysis for hemoglobinopathies reveals different mutation spectra in central Greece compared to the rest of the country. Am J Hematol. 2007;82(7):634–636.
   PubMed Web of Science ®Google Scholar
• Boussiou M, Karababa P, Sinopoulou K, et al. The molecular heterogeneity of β-thalassemia in Greece. Blood Cells Mol Dis. 2008;40(3):317–319.
   PubMed Web of Science ®Google Scholar
• Loukopoulos D. Haemoglobinopathies in Greece: prevention programme over the past 35 years. Indian J Med Res. 2011;134(4):572–576.
   PubMedGoogle Scholar
• Manitsa A, Theodoridou S, Stamna K, et al. Incidence of heterozygous carriers of haemoglobinopathies among immigrants in Northern Greece. Haema. 2002;5(2):115–117.
   Google Scholar
• Piel FB, Tatem AJ, Huang Z, et al. Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000. Lancet Glob Health. 2014;2(2):e80–e89.
   PubMed Web of Science ®Google Scholar
• Results of the population Census 2001 General Secretariat of Statistical Services in Greece. Hellenic Statistical Authority (http://www.statistics.gr).
   Google Scholar
• Modell B, Darlison M, Birgens H, et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest. 2007;67(1):39–79.
   PubMed Web of Science ®Google Scholar
• Roberts I, de Montalembert M. Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe. Haematologica 2007;92(7):865–871.
   PubMed Web of Science ®Google Scholar
• Modell B, Darlison M. Global epidemiology of hemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;2008 (6):480–487.
   Google Scholar
• Peters M, Fijnvandraat K, van den Tweel XW, et al. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening. Arch Dis Child. 2010;95(10):822–825.
   PubMed Web of Science ®Google Scholar
• Cataldo F. Immigration and changes in the epidemiology of hemoglobin disorders in Italy: an emerging public health burden. Ital J Pediatr. 2012;38:32
   PubMed Web of Science ®Google Scholar
• Theodoridou S, Alemayehou M, Prappas N, et al. Carrier screening and prenatal diagnosis of hemoglobinopathies. A study of indigenous and immigrant couples in Northern Greece, over the last 5 years. Hemoglobin. 2008;32(5):434–439.
   PubMed Web of Science ®Google Scholar
• Cousens NE, Gaff CL, Metcalfe SA, et al. Carrier screening for β-thalassaemia: a review of international practice. Eur J Hum Genet. 2010;18(10):1077–1083.
   PubMed Web of Science ®Google Scholar
• Wieacker P, Steinhard J. The prenatal diagnosis of genetic diseases. Dtsch Arztebl Int. 2010;107(48):857–862.
   PubMed Web of Science ®Google Scholar
• Voskaridou E, Ladis V, Kattamis A, et al. A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births. Ann Hematol. 2012;91(9):1451–1458.
   PubMed Web of Science ®Google Scholar
• Ladis V, Karagiorga-Lagana M, Tsatra I, et al. Thirty-year experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimisation. Eur J Haematol. 2013;90(4):313–322.
   PubMed Web of Science ®Google Scholar
• Amato A, Lerone M, Grisanti P, et al. Prevention strategies for severe hemoglobinopathies in endemic and non endemic migration countries: the Latium example. Prenat Diagn. 2009;29 (12):1171–1174.
   PubMed Web of Science ®Google Scholar
• Papadopoulos V, Vassiliadou D, Xanthopoulidis G, et al. The implications of Haemoglobin O-Arab mutation. Haema 2003;6:296–303.
   Google Scholar
• Giardine B, Borg J, Viennas E, et al. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2014;42(Database issue):D1063-D1069 (http://globin.cse.psu.edu).
   PubMed Web of Science ®Google Scholar
• Papadopoulos V, Vassiliadou D, Xanthopoulidis G, et al. The implications of Haemoglobin O-Arab mutation. Haema. 2003;6:296–303.
   Google Scholar
• Kaltsoya A, Ballas A, Sofroniadou K, et al. A mild β-thalassemia-Hemoglobin E disease. 5th Congress of the Asian and Pacific Society of Haematology, held in Istanbul, Turkey on September 1-6 1969. Abstract Book: 40
   Google Scholar
• Fessas P. Compound heterozygosity for Haemoglobin β and Hemoglobin E. Hemoglobin. 1991;15(4):345–246.
   PubMed Web of Science ®Google Scholar
• Theodoridou S, Plata E, Karababa P, et al. The first case of a compound heterozygosity for Hb E-Saskatoon and HbS. Haematologica. 2003;88(3):ECR08
   PubMedGoogle Scholar
• Tsistrakis GA, Scambardonis GJ, Klonizakis JP, et al. Haemoglobin D and β thalassaemia. A family report comprising 18 members. Acta Haematol. 1975;54(3):171–179.
   Web of Science ®Google Scholar
• Sinopoulou K, Lalou E, Karababa P, et al. A new β0 mutation, CD7 (G-T) in an Albanian. First report in the literature. 17th Panhellenic Haematological Congress, held in Athens, Greece on November 22-26 2006. Abstract Book: 78–79.
   Google Scholar
• Old J, Timbs A, McCarthy J, et al. New challenges in diagnosis of haemoglobinopathies: migration of populations. Proceedings of the 14th International Conference on Thalassaemia and Haemoglobinopathies and 16th Thalassaemia International Federation Conference for Patients and Parents held in Thessaloniki, Greece on November 17-19, 2017. Thalassaemia Reports, Proceedings Book. 2018;8:7474 (9-12).
   Google Scholar
• Koren A, Profeta L, Zalman L, et al. Prevention of β-thalassemia in Northern Israel — a cost-benefit analysis. Mediterr J Hematol Infect Dis. 2014;6(1):e2014012.
   PubMedGoogle Scholar
• Kauf TL, Coates TD, Huazhi L, et al. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009;84(6):323–327.
   PubMed Web of Science ®Google Scholar